These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 16606850)

  • 1. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.
    Wagner K; Zhang P; Rosenbauer F; Drescher B; Kobayashi S; Radomska HS; Kutok JL; Gilliland DG; Krauter J; Tenen DG
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6338-43. PubMed ID: 16606850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
    Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
    Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of C/EBPalpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation.
    Tavor S; Park DJ; Gery S; Vuong PT; Gombart AF; Koeffler HP
    J Biol Chem; 2003 Dec; 278(52):52651-9. PubMed ID: 14517214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells.
    Soliera AR; Lidonnici MR; Ferrari-Amorotti G; Prisco M; Zhang Y; Martinez RV; Donato NJ; Calabretta B
    Blood; 2008 Sep; 112(5):1942-50. PubMed ID: 18550858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.
    Shimamoto T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Fujimura T; Iwama H; Nakazawa S; Toyama K
    Blood; 1995 Oct; 86(8):3173-80. PubMed ID: 7579412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis.
    Koschmieder S; Göttgens B; Zhang P; Iwasaki-Arai J; Akashi K; Kutok JL; Dayaram T; Geary K; Green AR; Tenen DG; Huettner CS
    Blood; 2005 Jan; 105(1):324-34. PubMed ID: 15331442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of C/EBPalpha activity alters gene expression and differentiation of human CD34+ cells.
    Cammenga J; Mulloy JC; Berguido FJ; MacGrogan D; Viale A; Nimer SD
    Blood; 2003 Mar; 101(6):2206-14. PubMed ID: 12406909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.
    Chang JS; Santhanam R; Trotta R; Neviani P; Eiring AM; Briercheck E; Ronchetti M; Roy DC; Calabretta B; Caligiuri MA; Perrotti D
    Blood; 2007 Aug; 110(3):994-1003. PubMed ID: 17475908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion.
    Hayashi Y; Hirai H; Kamio N; Yao H; Yoshioka S; Miura Y; Ashihara E; Fujiyama Y; Tenen DG; Maekawa T
    Leukemia; 2013 Mar; 27(3):619-28. PubMed ID: 22948537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo.
    Sengupta A; Arnett J; Dunn S; Williams DA; Cancelas JA
    Blood; 2010 Jul; 116(1):81-4. PubMed ID: 20407032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the transcriptional repressor Gfi-1 is regulated by C/EBP{alpha} and is involved in its proliferation and colony formation-inhibitory effects in p210BCR/ABL-expressing cells.
    Lidonnici MR; Audia A; Soliera AR; Prisco M; Ferrari-Amorotti G; Waldron T; Donato N; Zhang Y; Martinez RV; Holyoake TL; Calabretta B
    Cancer Res; 2010 Oct; 70(20):7949-59. PubMed ID: 20924107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate.
    Schuster C; Forster K; Dierks H; Elsasser A; Behre G; Simon N; Danhauser-Riedl S; Hallek M; Warmuth M
    Blood; 2003 Jan; 101(2):655-63. PubMed ID: 12393654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
    Gross AW; Ren R
    Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.
    Iervolino A; Santilli G; Trotta R; Guerzoni C; Cesi V; Bergamaschi A; Gambacorti-Passerini C; Calabretta B; Perrotti D
    Mol Cell Biol; 2002 Apr; 22(7):2255-66. PubMed ID: 11884611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of C/EBPalpha and C/EBPbeta in BCR/ABL-expressing cells: differences and similarities.
    Guerzoni C; Ferrari-Amorotti G; Bardini M; Mariani SA; Calabretta B
    Cell Cycle; 2006 Jun; 5(12):1254-7. PubMed ID: 16760662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate.
    Era T; Witte ON
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1737-42. PubMed ID: 10677527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of C/EBPα expression with response and resistance to imatinib in chronic myeloid leukaemia.
    Kagita S; Uppalapati S; Gundeti S; Digumarti R
    Jpn J Clin Oncol; 2015 Aug; 45(8):749-54. PubMed ID: 25920395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells.
    Iotti G; Ferrari-Amorotti G; Rosafio C; Corradini F; Lidonnici MR; Ronchetti M; Bardini M; Zhang Y; Martinez R; Blasi F; Calabretta B
    Oncogene; 2007 May; 26(24):3482-91. PubMed ID: 17160016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
    Cuenco GM; Ren R
    Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.